In the latest close session, Abbott (ABT) was up +1.41% at $110.47. This move outpaced the S&P 500's daily gain of 0.46%. Elsewhere, the Dow gained 0.56%, while the tech-heavy Nasdaq added 0.45%. The ...

Abbott Laboratories (NYSE:ABT) launched Similac 360 Total Care Made With Whole Milk, a commercially sterile ready-to-feed ...

Fifty years after the worst mass murder in Bucks County history, the last surviving Abt family member talks about the crime ...

Valued at a market cap of $194.6 billion, Abbott Laboratories (ABT) is a global healthcare company that discovers, develops, ...

Fifty-years after she covered the worst mass murder in Bucks County history, a former reporter has revisited the events and ...

Abbott (NYSE: ABT) recently reported its Q4 results, with revenues marginally below and earnings meeting the street expectations. The company reported revenue of $10.97 billion and earnings of $1.34 ...

Abbott Laboratories is a Buy due to higher valuation, but expect low-teens annual total returns supported by strong fundamentals. Read more on ABT stock here.